Terms: = Breast cancer AND GNA11, GNA-11, 2767, ENSG00000088256 AND Treatment
8 results:
1. Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
Xu B; Sun T; Shi Y; Cui J; Yin Y; Ouyang Q; Liu Q; Zhang Q; Chen Y; Wang S; Wang X; Tong Z; Zhong Y; Wang J; Yan M; Yan X; Wang C; Feng J; Wang X; Hu G; Cheng Y; Ge R; Zhu Z; Zhang W; Shao Z
Breast Cancer Res Treat; 2023 Feb; 197(3):489-501. PubMed ID: 36459284
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma.
Teh JLF; Purwin TJ; Han A; Chua V; Patel P; Baqai U; Liao C; Bechtel N; Sato T; Davies MA; Aguirre-Ghiso J; Aplin AE
Mol Cancer Ther; 2020 Aug; 19(8):1719-1726. PubMed ID: 32430489
[TBL] [Abstract] [Full Text] [Related]
3. breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.
de Boniface J; Frisell J; Bergkvist L; Andersson Y
Br J Surg; 2018 Nov; 105(12):1607-1614. PubMed ID: 29926900
[TBL] [Abstract] [Full Text] [Related]
4. Novel therapeutic strategies and targets in advanced uveal melanoma.
Chua V; Aplin AE
Curr Opin Oncol; 2018 Mar; 30(2):134-141. PubMed ID: 29206651
[TBL] [Abstract] [Full Text] [Related]
5. Advanced Stage at Presentation Remains a Major Factor Contributing to breast cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country.
Kong YC; Bhoo-Pathy N; Subramaniam S; Bhoo-Pathy N; Taib NA; Jamaris S; Kaur K; See MH; Ho GF; Yip CH
Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28420149
[No Abstract] [Full Text] [Related]
6. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract] [Full Text] [Related]
7. Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic breast cancer: an Anatolian Society of Medical Oncology Study.
Uncu D; Bayoglu IV; Arslan UY; Kucukoner M; Artac M; Koca D; Oguz A; Demirci U; Arpaci E; Dogan M; Kucukzeybek Y; Turker I; Isikdogan A; Guler T; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):4127-31. PubMed ID: 25987098
[TBL] [Abstract] [Full Text] [Related]
8. Reduced expression of gna11 and silencing of MCT1 in human breast cancers.
Asada K; Miyamoto K; Fukutomi T; Tsuda H; Yagi Y; Wakazono K; Oishi S; Fukui H; Sugimura T; Ushijima T
Oncology; 2003; 64(4):380-8. PubMed ID: 12759536
[TBL] [Abstract] [Full Text] [Related]
